EUVIMEDEUVIMED entdecken
Crossref

Anisomycin inhibits the activity of human ovarian cancer stem cells via regulating antisense RNA NCBP2‐AS2/MEK/ERK/STAT3 signaling

Lele Ling, Yichao Wen, Ying Xiong, Xin Liu, Juan Chen, Te Liu, Bimeng Zhang

The Journal of Gene Medicine · 2024

DOI: 10.1002/jgm.3571 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Gene Medicine, 2024. Verfasst von Lele Ling und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Acupuncture, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Ovarian Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Shanghai Local High Level University Gaofeng Discipline.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ovarian cancer stem cells (OCSCs) are the main cause of relapse and drug resistance in patients with ovarian cancer. Anisomycin has been shown to be an effective antitumor agent, but its mechanism of action in ovarian cancer remains elusive.

Methods

CD44+/CD133+ human OCSCs were isolated from human ovarian cancer tissues. OCSCs were interfered with using anisomycin and specific small‐interfering RNA (siRNA). Microarray assay, MTT, in vivo tumorigenic experiments, transwell assay, cell cycle assay, colony formation assay, angiogenesis assay, and hematoxylin and eosin staining were used to detect the mechanism of anisomycin with respect to inhibiting the activity of OCSCs. Expression of the NCBP2‐AS2/mitogen‐activated protein kinase kinase (MEK)/extracellular signal‐regulated kinase (ERK)/signal transducer and activator of transcription 3 (STAT3) pathway was examined using western blotting, a quantitative real‐time PCR (RT‐qPCR) and immunofluorescence staining. Bioinformatics analysis was used for predictive analysis of NCBP2‐AS2 expression in urogenital tumors.

Results

Microarray analysis showed that treatment with anisomycin significantly decreased the expression of antisense RNA NCBP2‐AS2 in OCSCs. In vitro cellular experiments showed that interfering with endogenous antisense RNA NCBP2‐AS2 using siRNA distinctly inhibited the proliferation, migration and angiogenesis of OCSCs, whereas in vivo animal experiments revealed decreased tumorigenesis in nude mice. Moreover, the results of RT‐qPCR and western blotting demonstrated that both anisomycin treatment and NCBP2‐AS2 silencing led to significant reductions in the mRNA and protein expression levels of NCBP2‐AS2, MEK, ERK and STAT3. From a bioinformatic point of view, antisense RNA NCBP2‐AS2 exhibited significantly differential expression between urogenital tumors and normal controls, and a similar expression pattern was found in the genes NCBP2, RPL35A, DNAJC19 and ECE2, which have similarity to NCBP2‐AS2.

Conclusions

Anisomycin suppresses the in vivo and in vitro activity of human OCSCs by downregulating the antisense RNA NCBP2‐AS2/MEK/ERK/STAT3 signaling pathway, whereas the antisense RNA NCBP2‐AS2 and genes with similarity have the potential to serve as markers for clinical diagnosis and prognosis of urogenital tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsAnimalsMiceHumansFemaleAnisomycinRNA, AntisenseMitogen-Activated Protein Kinase KinasesSTAT3 Transcription FactorMice, NudeCell Line, TumorNeoplasm Recurrence, LocalSignal TransductionRNA, Small InterferingNeoplastic Stem CellsCell Proliferation

Stichwörter der Autor:innen

MEK/ERK/STAT3anisomycinantisense RNA NCBP2-AS2ovarian cancer stem cells (OCSCs)

Substanzen

AnisomycinRNA, AntisenseMitogen-Activated Protein Kinase KinasesSTAT3 Transcription FactorRNA, Small InterferingSTAT3 protein, human

Autor:innen und Institutionen

  • Department of Acupuncture, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Shanghai Geriatric Institute of Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Department of Obstetrics and Gynecology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Gongli Hospital Affiliated to the Second Military Medicical University in Pudong New Area of Shanghai City, Shanghai, China.

Förderung

  • Shanghai Local High Level University Gaofeng Discipline

Zitieren

APA

Ling, L., Wen, Y., Xiong, Y., Liu, X., Chen, J., Liu, T., & Zhang, B. (2024). Anisomycin inhibits the activity of human ovarian cancer stem cells via regulating antisense RNA NCBP2‐AS2/MEK/ERK/STAT3 signaling. The Journal of Gene Medicine. https://doi.org/10.1002/jgm.3571

Vancouver

Ling L, Wen Y, Xiong Y, Liu X, Chen J, Liu T, et al. Anisomycin inhibits the activity of human ovarian cancer stem cells via regulating antisense RNA NCBP2‐AS2/MEK/ERK/STAT3 signaling. The Journal of Gene Medicine. 2024. doi:10.1002/jgm.3571

BibTeX
@article{Ling2024,
  author = {Ling, Lele and Wen, Yichao and Xiong, Ying and Liu, Xin and Chen, Juan and Liu, Te and Zhang, Bimeng},
  title = {Anisomycin inhibits the activity of human ovarian cancer stem cells via regulating antisense RNA NCBP2‐AS2/MEK/ERK/STAT3 signaling},
  journal = {The Journal of Gene Medicine},
  year = {2024},
  doi = {10.1002/jgm.3571}
}
Kostenlos starten →